TroyGould Represents Lion Biotechnologies in $34.5 Million Underwritten Common Stock Offering

TroyGould represented Lion Biotechnologies, Inc., a biotechnology company that is developing novel cancer immunotherapies, in connection with its underwritten offering of 6,000,000 shares of common stock at $5.75 per share. The gross proceeds from the offering were $34.5 million.

Jefferies LLC and Cowen and Company, LLC acted as joint book-running managers and Trout Capital LLC acted as co-manager for the offering. The offering closed on December 22, 2014.